People who lost their eyesight or experienced NAION while taking Wegovy should talk to a lawyer about their legal options
(2023) Role of body mass index and weight change in the risk of cancer: A systematic review and meta-analysis of 66 cohort studies Ryan, Donna H., Ryan Yockey, Sarah (2018) Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and Over Magkos, Faidon, et al
Rosol TJ
These changes may reduce the potency of the medicine or produce degradation products that could affect tolerability
Compounded tirzepatide becomes a reasonable option when access barriers such as cost, insurance restrictions, or shortages prevent the use of FDA-approved Zepbound, provided you work with a qualified provider sourcing from a reputable 503B compounding facility
Post-Market Surveillance & Feedback Ongoing monitoring of the drugs safety and effectiveness continues after market launch